Oncostatin M Regulates the Synthesis and Turnover of gp130, Leukemia Inhibitory Factor Receptor α, and Oncostatin M Receptor β by Distinct Mechanisms

• Published in: The Journal of biological chemistry Vol. 276; no. 50; p. 47038
• Main Authors: Frédéric Blanchard, Yanping Wang, Erin Kinzie, Laurence Duplomb, Anne Godard, Heinz Baumann
• Format: Journal Article
• Language: English
• Published: American Society for Biochemistry and Molecular Biology 14.12.2001
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M107971200

The cytokine receptor subunits gp130, leukemia inhibitory factor receptor α (LIFRα), and oncostatin M receptor β (OSMRβ) transduce OSM signals that regulate gene expression and cell proliferation. After ligand binding and activation of the Janus protein-tyrosine kinase/STAT and mitogen-activated protein kinase signal transduction pathways, negative feedback processes are recruited. These processes attenuate receptor action by suppression of cytokine signaling and by down-regulation of receptor protein expression. This study demonstrates that in human fibroblasts or epithelial cells, OSM first decreases the level of gp130, LIFRα, and OSMRβ by ligand-induced receptor degradation and then increases the level of the receptors by enhanced synthesis. The transcriptional induction of gp130 gene by OSM involves STAT3. Various cell lines expressing receptor subunits to the different interleukin-6 class cytokines revealed that only LIFRα degradation is promoted by activated ERK and that degradation of gp130, OSMRβ, and a fraction of LIFRα involves mechanisms that are separate from signal transduction. These mechanisms include ligand-mediated dimerization, internalization, and endosomal/lysosomal degradation. Proteosomal degradation appears to involve a fraction of receptor subunit proteins that are ubiquitinated independently of ligand binding.